- Home
- VSA vs SONN Comparison
VSA vs SONN Comparison
Compare VSA & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSA
- SONN
- Stock Information
- Founded
- VSA 2002
- SONN N/A
- Country
- VSA China
- SONN United States
- Employees
- VSA N/A
- SONN N/A
- Industry
- VSA
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- VSA
- SONN Health Care
- Exchange
- VSA NYSE
- SONN Nasdaq
- Market Cap
- VSA 4.2M
- SONN 4.6M
- IPO Year
- VSA N/A
- SONN N/A
- Fundamental
- Price
- VSA $0.70
- SONN $1.28
- Analyst Decision
- VSA
- SONN Strong Buy
- Analyst Count
- VSA 0
- SONN 2
- Target Price
- VSA N/A
- SONN $38.00
- AVG Volume (30 Days)
- VSA 187.6K
- SONN 31.5K
- Earning Date
- VSA 05-21-2025
- SONN 05-16-2025
- Dividend Yield
- VSA N/A
- SONN N/A
- EPS Growth
- VSA N/A
- SONN N/A
- EPS
- VSA N/A
- SONN N/A
- Revenue
- VSA $190,004,403.00
- SONN $1,000,000.00
- Revenue This Year
- VSA $97.94
- SONN $5,376.22
- Revenue Next Year
- VSA N/A
- SONN N/A
- P/E Ratio
- VSA N/A
- SONN N/A
- Revenue Growth
- VSA N/A
- SONN 674.14
- 52 Week Low
- VSA $0.36
- SONN $1.10
- 52 Week High
- VSA $19,500.00
- SONN $16.00
- Technical
- Relative Strength Index (RSI)
- VSA N/A
- SONN 44.48
- Support Level
- VSA N/A
- SONN $1.30
- Resistance Level
- VSA N/A
- SONN $1.37
- Average True Range (ATR)
- VSA 0.00
- SONN 0.09
- MACD
- VSA 0.00
- SONN -0.01
- Stochastic Oscillator
- VSA 0.00
- SONN 13.79
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.